Adolfo Favaretto - Divisione di Oncologia Medica, Azienda Ospedaliera di Padova, Via Giustiniani 2, I-35128 Padova, Italy

基本信息

浏览量：29

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 21 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

9034 Medical treatment choices of over 1000 Italian patients affected by stage IIIB-IV NSCLC in routine clinical practice: results from the observational "SUN" (Survey on the lUng cancer maNagement) study on behalf of SUN study Group

S. Barni,E. Bajetta,F. De Marinis,L. Crinò,A. Ardizzoni,A. Caprioli,A. Favaretto,R. Giannicola,G. Filippelli,C. Gridelli

EJC SUPPLEMENTS（2009）

引用0浏览0引用

Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study

Alessandra Bearz,Isabella Garassino,Raffaele Cavina,Adolfo Favaretto,Massimo Boccalon,Renato Talamini,Massimiliano Berretta,Simon Spazzapan,Cecilia Simonelli,Armando Santoro,Umberto Tirelli

Lung Cancer（2008）

引用34浏览0WOS引用

Cisplatin Plus Gemcitabine Or Vinorelbine For Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Miles-2p Studies

Cesare Gridelli,Paolo Maione,Alfonso Illiano,Franco Vito Piantedosi,Adolfo Favaretto,Alessandra Bearz,Sergio Federico Robbiati,Virginio Filipazzi, Vito Lorusso,Francesco Carrozza,Rosario Vincenzo Iaffaioli,Luigi Manzione,

JOURNAL OF CLINICAL ONCOLOGY（2007）

引用127浏览0WOS引用

127

191 Pemetrexed in combination with carboplatin in elderly patients with malignant pleural mesothelioma

G L Ceresoli,B Castagneto,P A Zucali,Adolfo Favaretto,M Mencoboni, D De Giovanni,D Cortinovis, Maurizio Marangolo, F Grossi,G Del Conte,Anna Ceribelli,A Bearz,

LUNG CANCER（2006）

引用3浏览0引用

Two-drug gemcitabine-based first-line treatment of elderly patients with small-cell lung cancer (SCLC). The G-step program

A. Ceribelli,M. Paolo,F. Perrone,C. Gallo,S. Barbera,A. Favaretto,T. Gamucci,L. Isa,E. Piazza,N. Borsellino,V Zagonel,M. R. Valerio,

ANNALS OF ONCOLOGYno. SUPnan (2006): XI18-XI19

引用0浏览0引用

180 Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): A single center experience

F REA,G MARULLI,L BORTOLOTTI,C BREDA,A FAVARETTO,L LOREGGIAN,F SARTORI

LUNG CANCER（2006）

引用1浏览0引用

Phase II randomized trial of pemetrexed or sequentially-administered pemetrexed/gemcitabine for untreated advanced non-small cell lung cancer (NSCLC) in elderly or PS2 patients

C. Gridelli,M. Reck,V. Gregorc,M. Migliorino, T. R. Muller,C. Manegold,A. Favaretto,E. Crucitta, M. Munoz, L. Cirri, L. Marini,A. Rossi,

ANNALS OF ONCOLOGYno. SUPnan (2005): 28-29

引用0浏览0引用

P-428 A phase II study of pemetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelioma (MPM)

H SOTOPARRA,P ZUCALI,A FAVARETTO, F GROSSI,A FUSI, M MARANGOLO,G DELCONTE, A CERIBELLI,A BEARZ,G CERESOLI

Lung Cancer（2005）

引用2浏览0引用

Overview on ongoing or planned clinical trials in Europe

Adolfo Favaretto

Lung Cancer（2005）

引用21浏览0WOS引用

P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy

Cesare Gridelli, Martin Reck,Vanessa Gregorc,Maria Rita Migliorino, Thomas Muller,Ch Manegold,Adolfo Favaretto,Alexander Schmittel,Orazio Caffo, J Blatter,M Martinez Munoz, E Crucitta,

LUNG CANCER（2005）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn